CNPLE paediatric questions for Canadian nurse practitioners

Canadian NPs in primary care settings routinely manage the full paediatric continuum — from newborn well-baby assessments through adolescent health. This includes growth and developmental surveillance, immunisation programme delivery and counselling, acute illness management, anticipatory guidance, and coordination with paediatric specialty services when the presentation exceeds primary care scope.

The CNPLE reflects this scope. Paediatric competencies are not isolated to a single exam domain; they are embedded throughout the lifespan framework. A question about antibiotic selection for otitis media, a case presenting a child with developmental regression, and a scenario involving an adolescent with depression and suicidal ideation all test paediatric reasoning within the NP's independent practice scope.

Growth monitoring in Canada uses WHO growth charts for children under two and CDC-based references for older children. CNPLE-aligned preparation covers how to identify growth faltering, distinguish constitutional short stature from pathological causes, and determine when specialist referral is warranted — not just charting technique.

Developmental surveillance uses the Rourke Baby Record at each well-baby visit and the Nipissing District Developmental Screen for age-specific milestone checking. CNPLE questions may ask the NP to identify a developmental red flag (no babbling by 12 months, no single words by 16 months, loss of previously acquired skills at any age), determine the urgency of the concern, and initiate the appropriate referral pathway. The Autism Spectrum Disorder screening context — M-CHAT-R/F at 18 and 24 months — is a specific Canadian primary care standard relevant to CNPLE preparation.

Acute febrile illness in children requires the NP to distinguish benign viral illness from serious bacterial infection — applying age-specific risk stratification, recognising signs of sepsis or meningism, and selecting safe antipyretic management appropriate to the child's age and weight. Respiratory presentations including bronchiolitis (RSV season, supportive care principles), croup (stridor, severity assessment, dexamethasone use), and community-acquired pneumonia (clinical diagnosis, antibiotic selection by age and suspected organism) are consistently high-yield paediatric domains.

Otitis media management tests antibiotic selection (amoxicillin first-line, dosing by indication, watchful waiting criteria in children over two years), while gastroenteritis questions test oral rehydration therapy protocols and red flags for dehydration severity requiring escalation. Each of these presentations has Canadian-specific management guidance that CNPLE-aligned preparation should address directly.

Paediatric prescribing safety is a high-priority CNPLE domain. Weight-based dosing for common paediatric antibiotics (amoxicillin 40–90 mg/kg/day depending on indication, azithromycin, trimethoprim-sulfamethoxazole), appropriate formulation selection, and age-related contraindications (codeine in children under 12 due to ultra-rapid metaboliser risk, ASA avoidance for Reye syndrome) are all testable within NP prescriptive scope.

Adolescent prescribing adds confidentiality and consent dimensions specific to Canadian provincial law — understanding when an adolescent can consent to their own treatment without parental involvement is both a legal and ethical NP competency that may be tested in CNPLE professional practice scenarios.